PaxLovid

Pfizer's oral antiviral treatment for COVID-19, shown to reduce hospitalizations.

episodes

thinkers

of conversation

books & papers

terms defined

The neighbourhood: PaxLovid and the ideas it travels with. Drag to roam, click a star for the episode, click a neighbour to travel.

Drag to roam · scroll to zoom · click a neighbour to travel · click a star for the episode

From foundational to frontier

Climb the spectrum. The most accessible conversations come first.

Start here

ACCESSIBLECOREFRONTIER

1h 8m

05-28-26

Coming soon

Every term the guests lean on, in plain language. Read one in full, or filter to find it.

The throughline across every conversation that touches this idea.

Pfizer invested $2.3 billion in developing the COVID-19 vaccine, emphasizing breakthroughs over profit.

The FDA's 75-year data withholding request is due to a slow review process, not malintent.

Pfizer increased its vaccine production from 200 million to 3 billion doses annually.

PaxLovid reduces COVID hospitalizations significantly, showing 100% efficacy in trials against death.

Public trust in the pharmaceutical industry has declined, with reputation recovery being slow.

4 standout quotes from across the corpus.

4 books and papers cited across these episodes.

For the specialist

2 expert-level takeaways for a specialist reader.

At the frontier

1 open questions flagged across these conversations.

Who takes this idea on, by how often they return to it.